• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of VIP in pulmonary hypertension and application for the gene therapy

Research Project

Project/Area Number 20791088
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Anesthesiology/Resuscitation studies
Research InstitutionYokohama City University

Principal Investigator

KAWAKAMI Hiromasa  Yokohama City University, 附属病院麻酔科, 助教 (90407958)

Project Period (FY) 2008 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
KeywordsVIP / PACAP / PAC1受容体 / 肺高血圧 / プラスミドベクター / 先天性肺疾患 / 遺伝子治療 / 肺高血圧症 / 先天性心疾患
Research Abstract

Pulmonary hypertension (PH) is critical disease. It has been reported that neuropeptides VIP, PACAP involve in pulmonary circulation and respiratory system, however, their functions are not fully elucidated. The contents of VIP and PACAP in the lung decreased in experimental PH, while the expression of their receptors VPAC1, VPAC2 and PAC1 increased. Similar results were obtained from cardiac tissue. To verify the hypothesis that replacement of the peptides may improve PH, we constructed plasmid vector encoding VIP or PACAP. We have been investigating the more efficient method to deliver the plasmid and the effect in PH.

Report

(3 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report
  • Research Products

    (6 results)

All 2011 2010 2009 2008

All Presentation (6 results)

  • [Presentation] 実験的肺高血圧症におけるtoll-like receptor 4の関与とHeme oxygenase-1によるその抑制2011

    • Author(s)
      水野祐介、川上裕理、古賀資和、後藤隆久
    • Organizer
      日本麻酔科学会学術集会
    • Place of Presentation
      神戸(予定)
    • Year and Date
      2011-05-19
    • Related Report
      2009 Final Research Report
  • [Presentation] Attenuation of monocrotaline-induced pulmonary hypertension by heme oxygenase-1 involves toll-like receptor 4 signalings2010

    • Author(s)
      Hiromasa Kawakami, Yusuke Mizuno, Mokazu Koga, Takahisa Goto.
    • Organizer
      European Society of Anesthesiologists.
    • Place of Presentation
      Helsinki, Finland.
    • Year and Date
      2010-06-13
    • Related Report
      2009 Final Research Report
  • [Presentation] Altered expression of VIP/VPAC2 in hypertrophic right ventricle induced with monocrotaline in rats.2009

    • Author(s)
      Mokazu Koga, Yusuke Mizuno, Hiromasa Kawakami, Takahisa Goto.
    • Organizer
      American Society of Anesthesiologists.
    • Place of Presentation
      New Orleans , USA
    • Year and Date
      2009-10-20
    • Related Report
      2009 Final Research Report
  • [Presentation] Altered Expression of VIP/VPAC2 in Hypertrophic Right Ventricle Induced with Monocrotaline in Rats2009

    • Organizer
      American society of Anesthesiologysts, Annual Meeting 2009
    • Place of Presentation
      New Orleans, USA
    • Year and Date
      2009-10-20
    • Related Report
      2009 Annual Research Report
  • [Presentation] Effect of Hemin on Pulmonary Artery Pressure of Monocrotaline-Induced Pulmonary Hypertension in Rats2009

    • Author(s)
      川上裕理
    • Organizer
      American society of anesthesiologist
    • Place of Presentation
      Orland FL USA
    • Year and Date
      2009-10-20
    • Related Report
      2008 Annual Research Report
  • [Presentation] Effect of Hemin on Pulmonary Artery Pressure of monocrotaline-induced pulmonary hypertension in rats.2008

    • Author(s)
      Hiromasa Kawakami, Yusuke Mizuno, Mokazu Koga, Takahisa Goto.
    • Organizer
      American Society of Anesthesiologists.
    • Place of Presentation
      Orland, USA.
    • Year and Date
      2008-10-20
    • Related Report
      2009 Final Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi